We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

79 hedge funds and large institutions have $211M invested in VanEck Biotech ETF in 2017 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 25 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

255% more call options, than puts

Call options by funds: $3.8M | Put options by funds: $1.07M

24% more capital invested

Capital invested by funds: $170M → $211M (+$41.1M)

3.62% more ownership

Funds ownership: 29.58% → 33.2% (+3.6%)

8% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 25

8% less funds holding

Funds holding: 86 → 79 (-7)

43% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 14

Holders
79
Holders Change
-7
Holders Change %
-8.14%
% of All Funds
1.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
23
Reduced
25
Closed
14
Calls
$3.8M
Puts
$1.07M
Net Calls
+$2.73M
Net Calls Change
+$11.1M

Top Buyers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
+$28.2M
2
VF
Virtu Financial
New York
+$5.95M
3
MLL
Moody Lynn & Lieberson
Massachusetts
+$4.57M
4
TRCT
Tower Research Capital (TRC)
New York
+$3.03M
5
ACM
Aviance Capital Management
Florida
+$1.78M

Top Sellers

Rank Fund Capital Flow
1
CG
Colony Group
Massachusetts
-$4.79M
2
SG Americas Securities
SG Americas Securities
New York
-$2.58M
3
AL
Aspiriant LLC
California
-$2.5M
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$1.71M
5
Wells Fargo
Wells Fargo
California
-$1.69M
Name Holding Trade Value Shares
Change 		Change in
Stake
QAM
76
QCI Asset Management
New York
$3K – – –
MFW
77
Mosaic Family Wealth
Missouri
$1K – – –
AP
78
Advisors Preferred
Maryland
$21 +$20.2K +173 New
CG
79
Colony Group
Massachusetts
– -$4.79M -44,554 Closed
AL
80
Aspiriant LLC
California
– -$2.5M -23,280 Closed
Capital Fund Management (CFM)
81
Capital Fund Management (CFM)
France
– -$947K -8,800 Closed
RT
82
Rockland Trust
Massachusetts
– -$776K -7,216 Closed
OSNBOA
83
Old Second National Bank of Aurora
Illinois
– -$517K -4,804 Closed
SIG
84
Stanford Investment Group
California
– -$122K -1,138 Closed
HIIFS
85
Harel Insurance Investments & Financial Services
Israel
– -$105K -980 Closed
Bank of Montreal
86
Bank of Montreal
Ontario, Canada
– -$35K -325 Closed
CG
87
Cutler Group
California
– -$26.4K -226 Closed
FTUS
88
Flow Traders U.S.
New York
– -$22K -200 Closed
NFG
89
Next Financial Group
Texas
– -$19K -175 Closed
MIFH
90
Migdal Insurance & Financial Holdings
Israel
– -$16K -151 Closed
Envestnet Asset Management
91
Envestnet Asset Management
Illinois
– -$16K -144 Closed
Simplex Trading
92
Simplex Trading
Illinois
– -$15K -140 Closed
1 2 3
4

BBH Hedge Fund Activity: Q1 2017 in Review

79 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q1 2017, worth a combined $211M — up 24% from $170M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of BBH and 8 opened new positions — a net loss of 6 holders — while 25 trimmed existing stakes and 23 added.

The largest buyer was AllianceBernstein, adding an estimated $28.2M. The largest seller was Colony Group, exiting entirely with an estimated $4.79M sold.

  • 79 institutional investors held VanEck Biotech ETF (BBH) as of Q1 2017, down from 86 in Q4 2016.
  • Funds reported $211M of VanEck Biotech ETF stock for Q1 2017, up 24% quarter-over-quarter.
  • 8 funds opened new VanEck Biotech ETF positions in Q1 2017 and 14 closed out, a net change of -6 holders.
  • The largest VanEck Biotech ETF buyer in Q1 2017 was AllianceBernstein, an estimated $28.2M added.
  • The largest VanEck Biotech ETF seller in Q1 2017 was Colony Group, an estimated $4.79M sold.

Based on aggregated 13F filings for Q1 2017.